DMAA

Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQFinancial Services

$10.51+0.10%ClosedMarket Cap: $352.3M

As of 2026-04-06

Valuation

P/E (TTM)

61.51

PEG

—

P/B

1.05

P/S

0.00

EV/EBITDA

-484.85

DCF Value

—

FCF Yield

-0.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

3.4%

ROA

2.4%

ROIC

-0.3%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q3 2025	$0.00	NaN%	$-263.7K	$2.2M	$0.07	—
Q2 2025	$0.00	NaN%	$-131.9K	$2.3M	$0.07	—
Q1 2025	$0.00	NaN%	$-330.9K	$1.3M	$49.18	—
Q4 2024	$0.00	NaN%	$-279.00	$-279.00	$-0.03	—
FY 2024	$0.00	NaN%	$-479.00	$-479.00	$-0.06	—
Q3 2024	$0.00	NaN%	$-144.9K	$-144.9K	$-0.01	—
Q2 2024	$0.00	NaN%	$-54.93	$-54.93	$-0.01	—